Update [Study As­sess­ment]

posted by Helmut Homepage – Vienna, Austria, 2013-08-02 20:11 (4300 d 15:07 ago) – Posting: # 11176
Views: 25,686

Hi John!

❝ ❝ Splendid. Given your results chances that the product does not show a lower BA than the reference are ~0.00005%. Four questions: […]


❝ Hey they pay for for my bills, food, sports car etc etc :-P


I’m fine with most of it. Still I think that if we are not soooo much interested in ethics a – really better paid – job would be investment banker. BTW, not by any chance the first (!) question I was asked in my first workshop in India was: “Would you advise to open up a new CRO to make a lot of money?”
Telling!

❝ Remember I told you about my case a month or so ago? I had to deal with a drug product having ISCV~60% and T/R Ratio ~120% from a pilot study! They wanted me to go for a pivotal and also low-balled my sample size recommendation to ~70% of the computed sample size!


This story? Did you tell the guy in his Armani suit buying a new Lamborghini once its ash tray if full what that means in terms of power?

Thanks for your comprehensive example. ±2SD covers 95.45% of data – so such a cut-off is not completely out of the blue. BTW, Canada considers an outlier if the studentized intra-subject residual is >±3SD (i.e., covering 99.73% of data).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
133 visitors (0 registered, 133 guests [including 6 identified bots]).
Forum time: 11:18 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5